Thus, the functional characterization of BCL2L11 may be highly relevant to the IL-6-JAK-STAT3 pathway in the pathogenesis of NAFLD, which requires further experimental verification. The gene discussed is BCL2L11; the disease is metabolic dysfunction-associated steatotic liver disease.